The photo has been used for illustrative purpose.
The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people.
The trial announced on Saturday seeks to recruit 300 volunteers between the ages of 6 and 17, with up to 240 receiving the COVID-19 vaccine and the remainder a control meningitis vaccine.
AstraZeneca has a target to produce 3 billion doses this year and aims to produce over 200 million doses per month by April.
Andrew Pollard, chief researcher on the Oxford vaccine trial, says that while most children don’t get severely ill from COVID-19, "it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination.’’
Regulators in more than 50 countries have authorised widespread use of the Oxford vaccine, which is being produced and distributed by AstraZeneca, for use in people over the age of 18.
Other drug companies are also testing the COVID-19 vaccines in children. Pfizer, whose vaccine has already been authorized for use in people 16 and older, began testing its shot in children as young as 12 in October. Moderna in December began testing its vaccine on children as young as 12.
Pollard said the Oxford trial should help policymakers decide whether at some point in the future they want to extend mass vaccination programs to children as they seek to ensure schools are safe and combat the spread of the virus in the wider population.
"For most children, for themselves, COVID is really not a big problem…,’’ Pollard told The Associated Press. "However, it is certainly possible that wider use to try and curb the progress of the pandemic might be considered in the future, so here we’re just trying to establish the data that would support that if indeed policymakers wanted to go in that direction.”
Member states are struggling to contain a third wave of the epidemic and kick-start vaccine programmes slowed by a shortfall in deliveries, and Britain has warned the bloc against resorting "vaccine nationalism."
The fresh suspensions were a major blow to a global immunisation campaign that experts hope will help end a year-long pandemic that has already killed over 2.6 million people and decimated the global economy.
The announcement comes as the Ministry of Health and Prevention on Sunday expanded coronavirus vaccine eligibility in line with the UAE's proactive policy to ensure the health and safety of all community members.
Special Assistant to the Prime Minister on Political Communication Dr Shahbaz Gill held a fiery media conference in which he lashed out at Shirazi for criticising the government’s economic policies in her article.
Sheikh Mohammed exchanged cordial conversations with Simonyte about the bilateral relations between the two countries and ways to advance economic relations towards a new stage that achieves the interests of the two countries and their development aspirations in various fields of common interest, foremost of which are the sectors of advanced technology, innovation, and renewable energy.
This was announced by the Seismology Department of the National Centre of Meteorology (NCM), which monitors earthquake activities in the United Arab Emirates.
Sheikh Mohammed was accompanied during the visit by his sons, Sheikh Hamdan Bin Mohammed Bin Rashid Al Maktoum, Crown Prince of Dubai, Sheikh Maktoum Bin Mohammed Bin Rashid Al Maktoum, Deputy Ruler of Dubai, Ahmed Bin Mohammed Bin Rashid Al Maktoum, Chairman of the Dubai Media Council, and Sheikh Mansour Bin Mohammed Bin Rashid Al Maktoum.